Back to RecallTracker
Health Canada Health products

Immediate Recall by Mylan Pharmaceuticals: Potential Serious Risk due to Mislabelling of Products

Issued March 17, 2011
Issue
Following a complaint by a pharmacist regarding a prescription product containing the wrong medication, Mylan Pharmaceuticals has begun a voluntary recall of one lot (1037180) of Mylan-Minocycline 50 mg capsules, (bottles of 100) and Mylan-Amlodipine 5 mg tablets, (bottles of 100). The risk to a patient, who is sensitive or allergic to tetracyclines or minocycline, and is taking Mylan-Amlodipine to treat their high blood pressure or angina, but is now using Mylan-Minocycline due to a labelling error, can be life-threatening. In addition, a patient who requires Mylan-Amlodipine for their high blood pressure or angina will not get the medication needed to help them treat these conditions. The company is advising pharmacists and wholesalers to return all quantities of the lot (1037180) to Mylan Pharmaceuticals.
Hazard description
Labelling
What to do
Speak to your healthcare practitioner and pharmacist with any questions or concerns regarding further use of this product. Report any adverse reaction potentially related to these products to Health Canada (see below). Contact Mylan Pharmaceuticals concerning this recall at 1-800-575-1379